Marcus Aaron Horwitz

University of California, Los Angeles

NIH Rank #4322
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.3M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#4,322
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.3M across 3 grants · National rank #4322.

Top grants by award amount

Marcus Aaron Horwitz's NIH grant portfolio, ranked by award amount.

  • 1R01AI183978-01R01
    Efficacy and Safety of AI-enabled PRS Regimen VI (Clofazimine, Bedaquiline and Pyrazinamide) as Ultra-Short Course Therapy of LTBI in Non-Human Primates in a setting mimicking HIV co-infection
    $934.9K
    award amount
  • 5R01AI148122-04R01
    Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
    $780K
    award amount
  • 5R01AI151055-05R01
    Composition, Atomic Structure and Function of the Francisella Type 6 Secretion System, a Distinct Subtype Essential for Phagosomal Escape, Intracellular Replication, and Virulence
    $549.7K
    award amount

Affiliation

Institutions that have administered grants for Marcus Aaron Horwitz.

Affiliated with University of California, Los Angeles (CA).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of California, Los Angeles
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #4322
  6. 2024
    Entered Top 25% Nationally
    Ranked #4322